Mechanisms of Nuclear Import for Transfected Plasmid DNA in Mammalian Cells
Efficient DNA transfection in mammalian cells requires not only the delivery of plasmid DNA into the cytoplasm but also its successful transport into the nucleus, where transcription machinery can access and express the transgene. Nuclear import is a major rate-limiting step in non-viral gene delivery and significantly impacts the overall success of both transient and stable transfection workflows.
In dividing cells, nuclear envelope breakdown during mitosis offers a window through which plasmid DNA may passively diffuse into the nucleus. This passive access to the nuclear compartment explains the higher transfection efficiency typically observed in actively proliferating cell populations. However, in non-dividing or slowly dividing cells, such as neurons or primary immune cells, nuclear import must occur through active, regulated pathways across an intact nuclear envelope.
Plasmid DNA does not naturally contain nuclear localization signals (NLS), so it must rely on indirect mechanisms for nuclear import. One common strategy involves coupling the DNA to proteins or peptides containing NLS motifs, allowing the nuclear import machinery (primarily the importin α/β pathway) to recognize and shuttle the complex through nuclear pores. In some delivery systems, such as lipoplexes or polyplexes, the DNA binds to serum proteins or cellular factors post-entry that may facilitate nuclear trafficking by forming NLS-containing DNA-protein complexes.
Another important consideration is the role of DNA size and conformation in nuclear import. Smaller supercoiled plasmids typically exhibit improved import efficiency compared to larger or linearized DNA due to lower steric hindrance and better condensation within transfection complexes. Additionally, the inclusion of scaffold/matrix attachment regions (S/MARs) in plasmid backbones has been shown to improve nuclear retention and transcriptional activity, further enhancing gene expression levels post-transfection.
Advanced gene delivery systems have been designed to improve nuclear targeting. These include engineered nanoparticles with incorporated NLS peptides, biodegradable polymers that release DNA near the nuclear periphery, and light-activated or pH-responsive carriers that promote endosomal escape and nuclear approach in a temporally controlled manner.
Understanding and optimizing nuclear import pathways is essential for enhancing DNA transfection efficiency, particularly in hard-to-transfect or non-dividing cells. Continued investigation into the molecular details of nucleocytoplasmic transport will support the development of next-generation gene delivery systems for both research and therapeutic applications.
